ReviewDiabetes, obesity & metabolism2013

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

M Nauck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.